Text Size
38 studies found for:    physical | urticaria

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis;   Anaphylaxis
Intervention:
22 Completed Stem Cell Transplantation to Treat Systemic Mastocytosis
Condition: Mastocytosis
Intervention: Procedure: Stem cell transplantation
23 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
24 Recruiting Study of Mast Cell Precursors
Condition: Mastocytosis
Intervention:
25 Unknown † Molecular Mechanisms and Diagnosis of Mastocytosis
Condition: Mastocytosis
Intervention:
26 Completed Characteristics of Mast Cells in Mastocytosis
Condition: Mastocytosis
Intervention:
27 Terminated Effectiveness of Bradykinin Receptor Blocker at Reducing Swelling Associated With Angiotensin Converting Enzyme (ACE) Inhibitor-Associated Angioedema
Condition: Angioneurotic Edema
Interventions: Drug: HOE-140;   Other: Placebo
28 Completed Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: IMP: Icatibant, comparator: Tranexamic acid
29 Completed A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
30 Recruiting Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angioedema
Intervention: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
31 Recruiting A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Conditions: Smouldering Systemic Mastocytosis;   Indolent Systemic Mastocytosis;   Cutaneous Mastocytosis With Handicap;   Mastocytosis
Interventions: Drug: masitinib (AB1010);   Drug: placebo
32 Completed Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema
Condition: Angioedema
Intervention: Drug: Icatibant
33 Active, not recruiting Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
34 Completed
Has Results 		Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
35 Active, not recruiting A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
Conditions: Hereditary Angioedema;   C1 Esterase Inhibitor Deficiency
Intervention: Biological: C1 inhibitor (human)
36 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
37 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
38 Completed The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
Condition: Cryopyrin Associated Periodic Syndrome
Intervention: Drug: canakinumab (company code: ACZ885D)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page
† Indicates status has not been verified in more than two years